Pantethine
CAS 16816-67-4
Pantethine (CAS 16816-67-4) is a Phase 3 pharmaceutical compound with 1 bioactivity target and 58 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | AC50 | 30000 nM | 31 | - |
Adverse Event Associations
DrugCentral / FAERS disproportionality signal rows matched to this compound.
| Reaction PT | Drug AE | LLR | MedDRA |
|---|---|---|---|
| Platelet count decreased | 42 | 60.022 | 10035528 |
| Hepatic function abnormal | 27 | 53.852 | 10019670 |
| Ileus | 19 | 48.463 | 10021328 |
| Interstitial lung disease | 28 | 44.687 | 10022611 |
| Neutrophil count decreased | 25 | 41.732 | 10029366 |
| Pneumonia | 58 | 37.656 | 10035664 |
| Pyrexia | 57 | 36.833 | 10037660 |
| Salivary hypersecretion | 13 | 36.754 | 10039424 |
| Decreased appetite | 40 | 35.137 | 10061428 |
Association rows are source-linked signal records, not incidence rates or clinical causality claims.
Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| pantethine | 32863 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Pantethine used for in pharmaceutical contexts?
Pantethine (CAS 16816-67-4) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Pantethine?
Pantethine has 58 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Platelet count decreased, Hepatic function abnormal, Ileus, Interstitial lung disease, Neutrophil count decreased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Pantethine also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for PANTETHINE with EU status "permitted".
What clinical phase is Pantethine in?
Pantethine is rendered with ChEMBL max phase 3.